Oncotype DX Test Receipt among Latina/Hispanic Women with Early Invasive Breast Cancer in New Jersey: A Registry-Based Study

Oncotype DX(®) (ODX) is a valid test of breast cancer (BC) recurrence risk and chemotherapy benefit. The purpose of this study was to examine prevalence of and factors associated with receipt of ODX testing among eligible Latinas/Hispanics diagnosed with BC. Sociodemographic and tumor data of BC cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Acuna, Nicholas, Plascak, Jesse J., Tsui, Jennifer, Stroup, Antoinette M., Llanos, Adana A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151910/
https://www.ncbi.nlm.nih.gov/pubmed/34065945
http://dx.doi.org/10.3390/ijerph18105116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151910/
https://www.ncbi.nlm.nih.gov/pubmed/34065945
http://dx.doi.org/10.3390/ijerph18105116

Ejemplares similares